HOME >> BIOLOGY >> NEWS
Mouse stem cell line advance suggests potential for IVF-incompetent eggs

Researchers have found that mouse oocytes that fail to become fertilized during in vitro fertilization are nevertheless often capable of succeeding as "cytoplasmic donors" during a subsequent cloning step using so-called nuclear transfer. Although the implications for human eggs are not yet clear, the findings are of interest because of the ethical and practical concerns surrounding the need for fresh human oocytes for similar nuclear-transfer procedures using human cells. The findings, reported by Teruhiko Wakayama, Sayaka Wakayama, and colleagues at RIKEN Kobe in Japan, appear in the February 20th issue of the journal Current Biology, published by Cell Press.

Human IVF is now routinely practiced in fertility clinics, but a proportion of oocytes fail to become fertilized in these procedures. In the new work, researchers examined the ability of day-old mouse oocytes that fail to become fertilized in vitro"aged, fertilization-failure" (or AFF) oocytesto succeed in a standard cloning procedure in which the oocyte's nucleus is removed and replaced by the nucleus of a somatic cell. Although this nuclear-transfer procedure showed a lower rate of success in the very first stages of cloning compared to nuclear transfer with fresh oocytes, the early (morulae- or blastocyst-stage) mouse embryos derived from nuclear transfer using AFF oocytes showed similar rates of success in giving rise to embryonic stem cell lines.

None of the AFF-derived mouse embryos tested were capable of developing to full term, and in general, cloning by nuclear transfer sees a low success rate even when fresh eggs are used. But the authors indicate that nuclear-transfer protocols have yet to be perfected, and that the new findings suggest that once techniques required for human nuclear transfer have been optimized, it may be possible to use oocytes that failed to fertilize during IVF attempts and would otherwise be discarded.


'"/>

Contact: Erin Doonan
edoonan@cell.com
617-397-2802
Cell Press
19-Feb-2007


Page: 1

Related biology news :

1. Mouse model advances understanding of synovial sarcoma
2. Mouse FH knockout resembles human renal cell cancer
3. Mouse model underestimates the critical role of Tyk2 in human immune system
4. Mouse DNA to aid biomedical research
5. Mouse strain with gene stutter will help leukemia research
6. Knockout Mouse Project
7. NIH launches Knockout Mouse Project
8. Mouse mimics chronic leukemia, will aid drug development
9. Mouse, frog and bird put Snail and Slug to different uses
10. Mouse study reveals human X-SCID gene therapy poses substantial cancer risk
11. Mouse to man: The story of chromosomes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 19, 2020 , ... ... expo uniting life science, data science, informatics and IT leaders goes VIRTUAL and ... period of uncertainty and change, Bio-IT takes the leadership role of keeping our ...
(Date:8/7/2020)... , ... August 06, 2020 , ... ... participate in the prestigious National STEM Scholar Program, a unique professional development program ... and project support for middle school science teachers nationwide. , Created in partnership ...
(Date:7/22/2020)... ... July 21, 2020 , ... USDM Life Sciences ... compliance, announces a new solution to manage regulated workloads on Microsoft Azure. , ... technology stack complies with FDA and global regulations. USDM's new managed service for ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... HONG KONG (PRWEB) , ... July 09, 2020 ... ... chemical compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in ... years, the PolyU research team led by Dr MA has been using the ...
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World has announced ... Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the ... awards program, highlighting outstanding examples of how technology innovations and strategic initiatives can ...
(Date:7/1/2020)... Colo. (PRWEB) , ... June ... ... of expert tissue data insights, today announced that the launch of a ... results along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... ... to advance photodynamic therapy for treating cancer, today announced the company has entered ... (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park ...
Breaking Biology Technology:
Cached News: